These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16443880

  • 1. Serum lipids and the progression of nephropathy in type 1 diabetes.
    Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH.
    Diabetes Care; 2006 Feb; 29(2):317-22. PubMed ID: 16443880
    [Abstract] [Full Text] [Related]

  • 2. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Nawab SN, Shaikh R, Mahboob T.
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [Abstract] [Full Text] [Related]

  • 3. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [Abstract] [Full Text] [Related]

  • 4. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.
    Cardiovasc Diabetol; 2016 Jan 07; 15():3. PubMed ID: 26739836
    [Abstract] [Full Text] [Related]

  • 5. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
    Bulum T, Duvnjak L, Prkacin I.
    Acta Med Croatica; 2011 Jan 07; 65(3):243-50. PubMed ID: 22359892
    [Abstract] [Full Text] [Related]

  • 6. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?
    Bilous R.
    Diabet Med; 2008 Aug 07; 25 Suppl 2():25-9. PubMed ID: 18717975
    [Abstract] [Full Text] [Related]

  • 7. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ, Lewis JB.
    Clin Exp Nephrol; 2003 Mar 07; 7(1):1-8. PubMed ID: 14586737
    [Abstract] [Full Text] [Related]

  • 8. Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.
    Tolonen N, Forsblom C, Mäkinen VP, Harjutsalo V, Gordin D, Feodoroff M, Sandholm N, Thorn LM, Wadén J, Taskinen MR, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2014 Aug 07; 37(8):2374-82. PubMed ID: 24879842
    [Abstract] [Full Text] [Related]

  • 9. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan.
    Tseng CH.
    Clin Biochem; 2009 Jul 07; 42(10-11):1019-24. PubMed ID: 19324028
    [Abstract] [Full Text] [Related]

  • 10. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL, DCCT/EDIC Research Group.
    Kidney Int; 2003 Sep 07; 64(3):817-28. PubMed ID: 12911531
    [Abstract] [Full Text] [Related]

  • 11. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.
    Mäkinen VP, Soininen P, Kangas AJ, Forsblom C, Tolonen N, Thorn LM, Viikari J, Raitakari OT, Savolainen M, Groop PH, Ala-Korpela M, Finnish Diabetic Nephropathy Study Group.
    J Intern Med; 2013 Apr 07; 273(4):383-95. PubMed ID: 23279644
    [Abstract] [Full Text] [Related]

  • 12. Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.
    Tan KCB, Cheung CL, Lee ACH, Lam JKY, Wong Y, Shiu SWM.
    Diabetologia; 2018 May 07; 61(5):1212-1219. PubMed ID: 29417184
    [Abstract] [Full Text] [Related]

  • 13. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
    Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.
    Diabetes Care; 1999 Jul 07; 22(7):1176-80. PubMed ID: 10388985
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital.
    Wang SH, Wang L, Zhou Y, Guo YJ, Yuan Y, Li FF, Huang Y, Xia WQ.
    Diab Vasc Dis Res; 2013 Mar 07; 10(2):169-78. PubMed ID: 22906862
    [Abstract] [Full Text] [Related]

  • 15. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients.
    Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH.
    Diabetologia; 2003 Oct 07; 46(10):1402-7. PubMed ID: 12928771
    [Abstract] [Full Text] [Related]

  • 16. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
    Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P, Casale Monferrato Study.
    Diabetes Care; 2003 Jul 07; 26(7):2150-5. PubMed ID: 12832328
    [Abstract] [Full Text] [Related]

  • 17. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
    Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP.
    Kidney Int; 2003 Jan 07; 63(1):225-32. PubMed ID: 12472787
    [Abstract] [Full Text] [Related]

  • 18. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.
    Overgaard AJ, McGuire JN, Hovind P, Parving HH, Rossing P, Pociot F.
    J Diabetes Complications; 2013 Jan 07; 27(1):59-63. PubMed ID: 22885250
    [Abstract] [Full Text] [Related]

  • 19. Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
    Bjornstad P, Maahs DM, Wadwa RP, Pyle L, Rewers M, Eckel RH, Snell-Bergeon JK.
    J Clin Lipidol; 2014 Jan 07; 8(6):576-583. PubMed ID: 25499940
    [Abstract] [Full Text] [Related]

  • 20. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM, Hermans MP, Fioretto P, Valensi P, Davis T, Horton E, Wanner C, Al-Rubeaan K, Aronson R, Barzon I, Bishop L, Bonora E, Bunnag P, Chuang LM, Deerochanawong C, Goldenberg R, Harshfield B, Hernández C, Herzlinger-Botein S, Itoh H, Jia W, Jiang YD, Kadowaki T, Laranjo N, Leiter L, Miwa T, Odawara M, Ohashi K, Ohno A, Pan C, Pan J, Pedro-Botet J, Reiner Z, Rotella CM, Simo R, Tanaka M, Tedeschi-Reiner E, Twum-Barima D, Zoppini G, Carey VJ.
    Circulation; 2014 Mar 04; 129(9):999-1008. PubMed ID: 24352521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.